Neurable announced on April 28 that it has formally opened its consumer-EEG technology to original-equipment-manufacturer licensing, allowing third-party hardware makers to integrate the company’s brain-signal-processing stack into their own products without building the underlying neural-decoder capability themselves. The announcement names HP Inc.’s HyperX gaming division, MeSpace, the human-behaviour research platform iMotions, and the United States Air Force Research Laboratory among integration partners already working on Neurable-equipped products. BusinessWire carried Neurable’s primary press release, and TechCrunch published a CEO interview the same day. Dr. Ramses Alcaide, Neurable’s chief executive, framed the move as the start of a category shift: “let’s make this as ubiquitous as heart rate sensors on your wrist.”
The strategic distinction is platform versus product. Until April 28, Neurable was a Boston-based BCI company building its own consumer hardware, most visibly the HyperX-branded gaming headset launched at CES 2026 that collected category awards there. The licensing programme repositions the same underlying technology as a horizontal layer any consumer hardware maker can integrate, comparable to how ARM licenses processor cores or how Dolby licenses audio processing. For audio brands, eyewear companies, and headwear makers across categories, Neurable’s offer is access to BCI capability without internal R&D investment in the neural-decoder problem.
The HyperX precedent
The HyperX collaboration is the working proof-of-concept for the licensing model. The CES 2026 product is a gaming headset that uses EEG to track focus and cognitive state during gameplay, feeding the data into HP-branded software. The signal-processing stack ships inside a third-party brand’s product without the third party needing to acquire EEG-decoder expertise of its own. The licensing programme generalises that arrangement, with Neurable retaining ownership of its core technology stack while OEMs retain control over product design, user experience, and distribution.
The named partners
Beyond HyperX, the launch identifies three other integration partners. iMotions is a Copenhagen-based human-behaviour research platform widely used in academic and corporate behavioural research, which gains a Neurable EEG layer for cognitive-state measurement in research contexts. MeSpace is a less-publicly-disclosed wearable partner. The United States Air Force Research Laboratory is the most strategically significant of the three. A defence research customer using Neurable technology validates the platform for environments where signal reliability and ruggedisation matter, which has knock-on implications for industrial and operator-cognition applications outside defence. The defence integration also indirectly addresses the chronic credibility question facing consumer EEG: whether the signal quality survives at scale and outside laboratory conditions.
Funding and competitive position
Neurable closed its $35 million Series A in December 2025, bringing total funding raised to $65 million. Neurable’s competitive set sits outside the implantable BCI category. Neuralink, Synchron, and Paradromics are pursuing medical-device and accessibility outcomes that depend on cortical-resolution signal access, with surgical implantation, FDA Investigational Device Exemption pathways, and clinical-trial enrolment as the binding constraints. Neurable competes in the consumer-EEG layer: Emotiv, Muse, BrainCo’s focus and educational products, and the various startups attempting to embed EEG into eyewear and headwear. The licensing pivot is an attempt to compete on distribution rather than on hardware product, by routing through OEM partners rather than building Neurable-branded consumer devices.
The strategic consequence
For consumer hardware OEMs, the licensing programme compresses time-to-market for BCI-equipped products from years to months. An audio brand that wants brain-tracking features no longer needs to acquire an EEG-decoder team, build the algorithms, validate the signal-quality processing across form factors, or work out the privacy and consent architecture. Neurable’s offer is a productised version of all of that, a platform layer the OEM integrates rather than develops. Pricing has not been publicly disclosed, but the licensing-platform precedent in adjacent categories — Dolby for audio processing, ARM for compute, Qualcomm for cellular modems — suggests a per-unit royalty structure rather than a flat-fee model, which means Neurable’s revenue scales with OEM unit volumes.
The bigger thesis is that consumer BCI commercialises on platform economics rather than vertical-integration economics. If the licensing model produces serious OEM uptake over the next eighteen months, Neurable becomes a layer in the consumer-electronics stack rather than a hardware maker among many. If uptake stays thin, the HyperX collaboration remains a strong product but a strategic outlier. The data point to watch is the second branded OEM product to ship with Neurable inside, particularly if it lands in mainstream audio (Bose, Sony, Sennheiser, JBL) or eyewear (the consumer-AR category accelerating around Meta and Apple). That is the threshold above which the platform thesis stops being a press release and starts being a category-defining commercial reality.